(E)-3-(2-(Pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine
- CAS
- 886230-76-8
- Formula
- C19H20N4O
- MW
- 320.4 g/mol
VQ-035874
Impurity reference standards
Axitinib impurities & reference standards
Characterised Axitinib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
29reference materials
2isotope-labelled
COAHPLC · NMR · MS on request
Parent API: Axitinib WS
319460-85-0 · C22H18N4OS
(E)-6-Iodo-3-(2-(pyridin-2-yl)vinyl)-1H-indazole
- CAS
- 1952288-48-0
- Formula
- C14H10IN3
- MW
- 347.15 g/mol
VQ-035876
![(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole chemical structure](/media/structures/QXJFRDDGGSSQDX-CSKARUKUSA-N.svg)
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
- CAS
- 886230-77-9
- Formula
- C19H18IN3O
- MW
- 431.3 g/mol
VQ-021689
(E)-N-Methyl-2-((1-(2-(pyridin-2-yl)ethyl)-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
- CAS
- 1443118-72-6
- Formula
- C29H25N5OS
- MW
- 491.6 g/mol
VQ-029313
2-((1-Acetyl-1H-indazol-6-yl)sulfinyl)-N-methylbenzamide
- CAS
- 1959572-98-5
- Formula
- C17H15N3O3S
- MW
- 341.4 g/mol
VQ-024457
2-((1H-Indazol-6-yl)sulfinyl)-N-methylbenzamide
- CAS
- 1959572-97-4
- Formula
- C15H13N3O2S
- MW
- 299.3 g/mol
VQ-024456
2-((3-Iodo-2H-indazol-6-yl)thio)-N-methylbenzamide
- CAS
- 885126-34-1
- Formula
- C15H12IN3OS
- MW
- 409.2 g/mol
VQ-035875
![2,2'-Dithiobis[N-methyl-benzamide] chemical structure](/media/structures/JEVCLNJEBFWVPD-UHFFFAOYSA-N.svg)
3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
- CAS
- 886230-74-6
- Formula
- C12H12IN3O3
- MW
- 373.15 g/mol
VQ-043873
N-Methyl-2-((3-(2-(pyridin-2-yl)ethyl)-1H-indazol-6-yl)thio)benzamide
- CAS
- 1443118-73-7
- Formula
- C22H20N4OS
- MW
- 388.5 g/mol
VQ-024458
![N-Methyl-2-[[3-[(1E)-2-(1-oxido-2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfinyl]-benzamide chemical structure](/media/structures/MESVCUNKPBREDN-UUAZFVJBSA-N.svg)
N-Methyl-2-[[3-[(1E)-2-(1-oxido-2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfinyl]-benzamide
- CAS
- 1348044-24-5
- Formula
- C22H18N4O3S
- MW
- 418.5 g/mol
VQ-029312
FAQs — Axitinib impurities
Which Axitinib impurities do you supply?
We list 29 Axitinib-related reference materials, including process impurities, degradation products, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Axitinib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Axitinib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Axitinib impurity standards
We reply within one business day with price, pack options, lead time and documentation.